Papers using
ERK1
antibodies
A dual epigenomic approach for the search of obesity biomarkers: DNA methylation in relation to diet-induced weight lossDhar M. S. et al., In Journal of Nutrition and Metabolism, 2010
... Primary antibodies (p38, phospho-p38, JNK, phospho-JNK, p44/42, and phospho-p44/42) as well as the secondary antibody, horseradish peroxidase- (HRP-) conjugated anti-rabbit IgG, were obtained from Cell Signaling Technology (Danvers, MA) ... zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation.Gires Olivier, In PLoS ONE, 2010
... chain 3 (LC3), Atg5, Atg7, Beclin-1, caspase 3, caspase 9, PARP, GAPDH, non-phospho- or phospho-MEK1/2 and ERK1/2 were from Cell Signaling Technology, Inc. ... more suppliers
Papers on
ERK1
Filling in the gaps in cranial suture biology.Fitzpatrick, Edinburgh, United Kingdom. In Nat Genet, 31 Mar 2013
Two new loci for premature fusion of the cranial sutures in humans suggest a common endpoint in osteoblast regulation, linking upregulation of phosphorylated ERK1/2 and TWIST1 haploinsufficiency.
Cross-talk in nucleotide signaling in glioma C6 cells.Barańska et al., Warsaw, Poland. In Adv Exp Med Biol, Dec 2012
In glioma C6, these two P2Y receptors modulate activities of ERK1/2 and PI3K/Akt signaling and the effects depend on physiological conditions of the cells.
[Systemic distribution of prorenin and its receptor].Shichiri et al., United States. In Nihon Rinsho, Sep 2012
This receptor binds to prorenin to mediate its dual functions: activation of ERK1/2 independently from angiotensin II generation and induction of full enzymatic activity to initiate angiotensin II-dependent effects.
More papers using
ERK1
antibodies
DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cellsBerghe Wim Vanden et al., In Molecular Cancer, 2007
... (C19), anti-Fra1(H50), anti-Nrf2 (C10), anti-Bax antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA), anti-p38, anti-p44/42, anti-cfos, anti-cjun, anti-junB, anti-junD from Active Motif, anti-Sirt1 from Biomol, anti-Stat3 ... Nuclear actin dynamics–from form to function.Tyagi Anil Kumar, In PLoS ONE, 2007
... Phospho-specific and nonphospho-specific antibodies against ERK1/2, nonmuscle myosin II, and fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse secondary and anti-FITC–HRP antibodies were obtained from Abcam. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.Schneider-Stock Regine, In PLoS ONE, 2006
... (Sigma), Myc (Santa Cruz), PP1A (Epitomics), GST (Santa Cruz), YAP2 (Santa Cruz), Phospho-Ser127-YAP2 (Cell Signaling), Erk1/2 (Cell Signaling), Actin (SIGMA), GAPDH (SIGMA) ... Knocking out peroxisome proliferator-activated receptor (PPAR) alpha inhibits radiation-induced apoptosis in the mouse kidney through activation of NF-kappaB and increased expression of IAPs.Ulasov Ilya, In PLoS ONE, 2006
... Antibodies for c-Jun (sc-45), phosphorylated c-Jun (Ser73, sc-7981), ERK1 (sc-94), phosphorylated ERK1/2 (Thr202/Thr204, sc-81492), phosphorylated MEK (sc-7995R), COX-2 (sc-1745) and HA (sc-7392) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) ... TOR signaling in growth and metabolismPatel Tarun B. et al., In Oncogene, 2005
... Anti-phospho Src (Ser-416 and Ser-527), anti-phospho-Akt (Ser-473), anti-phospho-S6 kinase (Thr 389), anti-phospho-RSK (Thr-573), and anti-phospho-Erk1/2 (Thr-202/Tyr-204) antibodies were purchased from Cell Signaling (Beverly, MA) ... Method of preparation of Curcurbitacin IIa as anti-cancer drugsLu Q et al., In British Journal of Cancer, 2005
... PARP, cleaved PARP, Histone H3, STAT3, phospho-STAT3 (tyrosine 705), JAK2, phospho-JAK2 (tyrosine 1007/1008), ERK1/2, and phospho-ERK1/2, were from Cell Signaling (Danvers, MA, USA) ... Functional analysis of PIK3CA gene mutations in human colorectal cancer.Shellman Yiqun G., In PLoS ONE, 2004
... anti-phospho-HER2 antibodies were purchased from Upstate Biotechnology, Anti-phospho-EGFR, anti-EGFR, anti-phospho-HER3, anti-phospho-c-Met, anti-phospho-Akt, anti-Akt, anti-PTEN, anti-phospho-ERK1/2, anti-ERK1/2, and mutation-specific (L858R in exon 21 and deletion E746-A750 in exon 19) antibodies were from Cell Signaling Technology, anti-HER3 and anti-c-Met ... Among circulating hematopoietic cells, BCLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosisKooijman R. et al., In Cellular and Molecular Life Sciences, 2003
... rabbit antibodies against Pp38, ERK1/2, P-JNK, JNK, P-CREB and CREB, and the mouse monoclonal against P-ERK1/2 were obtained from Cell Signaling (Beverly, Mass.) ... Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesisVermes I. et al., In International Journal of Cell Biology, 2003
... following companies: caveolin-1 (Sigma, Mo, USA; C4490), Akt (Abcam (Cambridge, UK); ab28422), phospho-Akt (Abcam, ab27773), ERK1 (Abcam, ab9363), phospho-ERK (Santa Cruz, ... Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signalingLowenstein Charles J. et al., In The Journal of Experimental Medicine, 2002
... ERK1/2, phospho-ERK1/2, phospho-MEK1/2, phospho-Raf, phospho-Elk-1, phospho-p90, p38, phospho-p38, JNK, phospho-JNK, phospho-Raf and acetyl-K, phospho-MKK3/6, and MKK3 were purchased from Cell Signaling Technology ... Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repairTurley Eva A. et al., In The Journal of Cell Biology, 1997
... muscle actin (immunohistochemistry), nonimmune IgG (Santa Cruz Biotechnology, Inc.), Ki67 (immunohistochemistry; DakoCytomation), tenascin (immunohistochemistry; Chemicon), phospho-ERK1,2 (immunohistochemistry/Western blot/immunofluorescence; Cell Signaling), CD44 (Western blot/immunofluorescence/blocking; IM7; ... Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processesGuicheux Jérôme et al., In Stem Cells (Dayton, Ohio), 1990
... (3101), phospho-extracellular signal-regulated kinase (ERK)1/2 (9101), phospho-c-Jun N-terminal kinase (JNK)1/2 (9251), phospho-p38 (9211), SMAD 2 (3102), ERK1/2 (9102), and goat anti-rabbit IgG horseradish peroxidase (HRP)–linked (7074) antibodies were purchased from Cell Signaling Inc ... BOXSHADE 3.21Hardie D Grahame et al., In Journal of Biology, 1983
... Anti-Erk1/2 antibodies were from Cell Signaling Technology (New England Biolabs, ... An effect human leukaemic cell line: RehNaderi Soheil et al., In Molecular Cancer, 1976
... phospho-IκBα (S32; #2859), p65 (#3034), IKKα (#2682), IKKβ (#2684), phospho-IKKα/β (S176/S180; #2697), ERK1/2 (#9102), and phosphor-ERK1/2 (T202/Y204; #9101) were from Cell Signaling Technology ...